Advancing the field of pharmaceutical risk minimization through application of implementation science best practices.
Regulators are increasingly mandating the use of pharmaceutical risk-minimization programs for a variety of medicinal products. To date, however, evaluations of these programs have shown mixed results and relatively little attention has been directed at diagnosing the specific factors contributing t...
| Publicado en: | Drug Safety Vol. 37; no. 8; pp. 569 - 581 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Aug2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |